ZA733571B - Intravenously tolerated anti-distemper and anti-hepatitis vaccine,its preparation and its use for immunization - Google Patents

Intravenously tolerated anti-distemper and anti-hepatitis vaccine,its preparation and its use for immunization

Info

Publication number
ZA733571B
ZA733571B ZA733571A ZA733571A ZA733571B ZA 733571 B ZA733571 B ZA 733571B ZA 733571 A ZA733571 A ZA 733571A ZA 733571 A ZA733571 A ZA 733571A ZA 733571 B ZA733571 B ZA 733571B
Authority
ZA
South Africa
Prior art keywords
distemper
immunization
preparation
hepatitis vaccine
intravenously
Prior art date
Application number
ZA733571A
Other languages
English (en)
Inventor
O Ackermann
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of ZA733571B publication Critical patent/ZA733571B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175—Canine distemper virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G10—MUSICAL INSTRUMENTS; ACOUSTICS
    • G10L—SPEECH ANALYSIS TECHNIQUES OR SPEECH SYNTHESIS; SPEECH RECOGNITION; SPEECH OR VOICE PROCESSING TECHNIQUES; SPEECH OR AUDIO CODING OR DECODING
    • G10L15/00—Speech recognition
    • G10L15/22—Procedures used during a speech recognition process, e.g. man-machine dialogue
    • G10L2015/226—Procedures used during a speech recognition process, e.g. man-machine dialogue using non-speech characteristics
    • G10L2015/227—Procedures used during a speech recognition process, e.g. man-machine dialogue using non-speech characteristics of the speaker; Human-factor methodology
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA733571A 1972-05-26 1973-05-25 Intravenously tolerated anti-distemper and anti-hepatitis vaccine,its preparation and its use for immunization ZA733571B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2225548A DE2225548C3 (de) 1972-05-26 1972-05-26 Intravenös verträglicher Impfstoff gegen Staupe- und Hepatite contagiosa canis

Publications (1)

Publication Number Publication Date
ZA733571B true ZA733571B (en) 1974-04-24

Family

ID=5845894

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA733571A ZA733571B (en) 1972-05-26 1973-05-25 Intravenously tolerated anti-distemper and anti-hepatitis vaccine,its preparation and its use for immunization

Country Status (13)

Country Link
US (1) US3886270A (de)
AR (1) AR201193A1 (de)
AT (1) AT336779B (de)
AU (1) AU467451B2 (de)
BE (1) BE800132A (de)
CA (1) CA1020461A (de)
DE (1) DE2225548C3 (de)
DK (1) DK141055C (de)
FR (1) FR2189023B1 (de)
GB (1) GB1437006A (de)
NL (1) NL163428C (de)
SE (1) SE7608007L (de)
ZA (1) ZA733571B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL133476B1 (en) * 1981-06-10 1985-06-29 Akad Medyczna Method of obtaining pure antigen hba from human serum
US4990367A (en) * 1987-03-09 1991-02-05 Diamond Scientific Company Canine distemper virus vaccine
US5000951A (en) * 1987-03-09 1991-03-19 Diamond Scientific Company Multivalent canine distemper virus vaccine
CN105884889A (zh) * 2016-04-18 2016-08-24 内蒙古神元生物工程股份有限公司 犬瘟热-传染性肝炎-细小病毒三联卵黄抗体及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470294A (en) * 1961-06-21 1969-09-30 Behringwerke Ag Vaccine for immunization of dogs and foxes against distemper,hepatitis contagiosa and leptospirosis and process for preparing it
US3316153A (en) * 1965-03-29 1967-04-25 Lilly Co Eli Virus purification
US3519400A (en) * 1967-01-25 1970-07-07 Atomic Energy Commission Method of centrifugal separation and recovery of chemical species utilizing a liquid medium

Also Published As

Publication number Publication date
AR201193A1 (es) 1975-02-21
DK141055C (da) 1980-06-23
NL163428B (nl) 1980-04-15
DE2225548C3 (de) 1980-05-29
NL163428C (nl) 1980-09-15
BE800132A (fr) 1973-11-28
CA1020461A (en) 1977-11-08
FR2189023A1 (de) 1974-01-25
AT336779B (de) 1977-05-25
US3886270A (en) 1975-05-27
AU467451B2 (en) 1975-12-04
DK141055B (da) 1979-12-31
AU5612573A (en) 1974-11-28
DE2225548B2 (de) 1979-09-06
DE2225548A1 (de) 1973-12-06
ATA459273A (de) 1976-09-15
NL7306986A (de) 1973-11-28
GB1437006A (en) 1976-05-26
FR2189023B1 (de) 1976-12-03
SE7608007L (sv) 1976-07-13

Similar Documents

Publication Publication Date Title
GB1423617A (en) Back rests for chairs or the like
NL170229C (nl) Farmaceutisch combinatiepreparaat.
BE787901A (fr) Vaccin antivariolique
ZA717345B (en) Pharmaceutical preparation
IL42275A0 (en) Copolymers of diallyldialkyl-ammonium compounds,membranes made thereof and the preparation of these membranes
ZA724983B (en) Pharmaceutical preparations
BE794307A (fr) Vaccin anti-caries
ZA733571B (en) Intravenously tolerated anti-distemper and anti-hepatitis vaccine,its preparation and its use for immunization
IE36042L (en) Secretin preparation.
CA1012555A (en) Amino phenyltetralin compounds and methods for the preparation thereof
ZA735221B (en) Improved dosage regimen
IE35695L (en) Virus preparation
AU451635B2 (en) Vaccine preparation
IL40597A0 (en) Antihypertensively pharmaceutical preparations
AU456693B2 (en) Improvements; in virus vaccines
IT7830643A0 (it) Vaccino anti-tifo e procedimento per la sua preparazione.
ZA714076B (en) Pharmaceutical preparation
AU4984672A (en) Vaccine adjuvants
AU4173472A (en) Vaccine
ZA721169B (en) Pharmaceutical preparation
ZA713227B (en) Pharmaceutical preparation
CA905848A (en) Vaccines
IE38154L (en) Immunological adjuvants for vaccines.
CA853671A (en) Vaccines
CA857299A (en) Vaccines